# Can SS-31 (Elamipretide) improve mitochondrial function in aging muscle tissue?

Canonical source: https://retacompare.com/research/can-ss-31-elamipretide-improve-mitochondrial-function-in-aging-muscle-tissue

Peptide Longevity Q&A · 2026-01-01


    Research indicates that SS-31 (Elamipretide) enhances mitochondrial function in models of mitochondrial trifunctional protein deficiency. This improvement is linked to increased exercise endurance and mitochondrial bioenergetics, suggesting potential benefits for age-related muscle decline.

 What the research shows

The study investigated the effects of SS-31 (Elamipretide) on mitochondrial function in both mitochondrial trifunctional protein (TFP)-deficient mice and human fibroblasts. Mice were treated with elamipretide via an osmotic minipump and subjected to treadmill exercise or cold stress following fasting. The results demonstrated that elamipretide improved exercise endurance in TFP-deficient mice, although cold tolerance remained unchanged. Additionally, liver mitochondria from these mice exhibited enhanced fatty acid oxidation and electron transport chain (ETC) enzyme activities. In human fibroblasts, elamipretide led to a possible genotype-dependent increase in mitochondrial bioenergetics and a reduction in reactive oxygen species (ROS), indicating a potential mechanism for improved mitochondrial function.

 Why it matters for longevity

The findings from this research are significant in the context of aging and longevity. Mitochondrial dysfunction is a key factor in age-related decline, affecting muscle strength, endurance, and overall metabolic health. By improving mitochondrial function, SS-31 (Elamipretide) may help mitigate some of the physical declines associated with aging. Enhanced exercise endurance in particular could contribute to better overall fitness and healthspan, allowing older adults to maintain an active lifestyle. This aligns with the broader goal of developing therapies that support healthy aging through targeted interventions in mitochondrial health.

 Key findings at a glance

SS-31 (Elamipretide) improves exercise endurance in TFP-deficient mice.

Liver mitochondria showed enhanced fatty acid oxidation and ETC enzyme activities.

Elamipretide reduced reactive oxygen species in patient-derived fibroblasts.

Cardiolipin content and composition remained unchanged despite treatment.

The effects of elamipretide may be genotype-dependent.

 How SS-31 (Elamipretide) works (background)

SS-31 (Elamipretide) is a synthetic peptide that binds to cardiolipin, a lipid crucial for mitochondrial function. It plays a role in stabilizing the interaction between fatty acid oxidation enzymes and the electron transport chain, thereby enhancing mitochondrial bioenergetics. By improving the efficiency of these metabolic processes, elamipretide can potentially counteract the effects of mitochondrial dysfunction, which is often exacerbated in aging and various metabolic disorders. The peptide's ability to reduce oxidative stress further contributes to its potential therapeutic effects.

 Safety, caveats, and what we don't yet know

While the study demonstrates promising results for SS-31 (Elamipretide) in preclinical models, it is essential to recognize limitations. The research primarily focuses on TFP-deficient mice and human fibroblasts, which may not fully represent broader aging populations. Further studies are needed to assess long-term safety, efficacy, and potential side effects in older adults and diverse populations. Additionally, the specific mechanisms underlying the genotype-dependent responses observed in fibroblasts require further investigation to clarify their implications for therapeutic use.

 Bottom line

SS-31 (Elamipretide) shows potential in improving mitochondrial function, particularly in enhancing exercise endurance, which may have implications for aging muscle tissue.

 Related questions

 Does SS-31 (Elamipretide) help with age-related muscle decline?

Research suggests that SS-31 (Elamipretide) may improve mitochondrial function, which is crucial for muscle health, potentially helping to mitigate age-related muscle decline.

 What are the potential benefits of SS-31 (Elamipretide) for metabolic disorders?

SS-31 (Elamipretide) has shown promise in enhancing mitochondrial bioenergetics and reducing oxidative stress, which may benefit individuals with metabolic disorders linked to mitochondrial dysfunction.

 How does mitochondrial function relate to aging?

Mitochondrial function declines with age, contributing to decreased energy production and increased oxidative stress, which are associated with various age-related health issues.

 Source: PubMed · J Inherit Metab Dis · published 2026-01-01.

## Sources

- PubMed · J Inherit Metab Dis: https://pubmed.ncbi.nlm.nih.gov/41500837/